Official 2024 U.S. DOL Form 5500 summary for Spaulding Clinical Research (Spaulding Clinical Research 401(k) Plan · EIN 26-0647166 · PN 001): $5.02M net assets, 131 active participants, and $79.08 per $10,000 (79.08 bps).
| Plan Sponsor | Spaulding Clinical Research |
|---|---|
| Filing Identifier | Spaulding Clinical Research 401(k) Plan · EIN 26-0647166 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (WI) |
| Asset-Size Peer Cohort | $1M-$5M |
| Plan Net Assets (2024) | $5.02M |
| Active Participants | 131 |
| Direct Admin Fee Rate | $79.08 per $10,000 (79.08 bps) |
| Cohort Peer Median | $63.02 per $10,000 (63.02 bps) |
| Primary Recordkeeper / Provider | Transamerica |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($573,603, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI